Clinical Trials Directory

Trials / Terminated

TerminatedNCT00625040

Incretin Physiology and Beta-cell Function Before and After Weight-loss

Incretin Physiology and Beta-cell Function Before and After Weight-loss - Effects of Long-term Weight Loss Following Laparoscopic Adjustable Gastric Banding

Status
Terminated
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Glostrup University Hospital, Copenhagen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate the impact of laparoscopic adjustable gastric banding (LAGB) on beta-cell function, insulin sensitivity, incretin function, postprandial secretion of incretin hormones (glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)) in morbidly obese patients and to describe the pathophysiological mechanisms involved in the amelioration of glucose homeostasis during long-term weight loss.

Detailed description

Morbid obesity represents a serious health issue in Western countries, with a rising incidence and a strong association with increased mortality and serious co-morbidities, such as diabetes. Surgical interventions, such as laparoscopic gastric banding have been developed with the aim of providing a laparoscopic placed device that is safe and effective in generating substantial weight loss. By investigation of the incretin effect, the secretion of GIP and GLP-1, the insulin response and sensitivity and the beta-cell responsiveness to glucose in 10 obese patients without type 2 diabetes before and after laparoscopic gastric banding the aim of this project is describe the pathophysiological mechanisms involved in the amelioration of glucose homeostasis during long-term weight loss.

Conditions

Interventions

TypeNameDescription
OTHEROral glucose tolerance test (OGTT), isoglycemic iv. clamp, liquid meal test, gastric emptying rateOGTT: The test is performed with 50 g of glucose deluded in 300 ml water Isoglycemic iv. clamp: Iv. glucose infusion mimicking the glucose response curves from the OGTT Liquid Meal test: The test is performed with 100g of formula milk deluded in 300 ml. water Gastric Emptying Rate: Paracetamol absorption test.

Timeline

Start date
2008-01-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2008-02-28
Last updated
2014-10-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00625040. Inclusion in this directory is not an endorsement.